Results for tag: "Long Acting Injectable"

The Long Acting Injectable (LAI) market is a segment of the medical device industry that focuses on the development and production of injectable drugs that are designed to provide sustained therapeutic effects over a longer period of time. LAI drugs are typically administered via intramuscular or subcutaneous injection, and are used to treat a variety of chronic conditions, including mental health disorders, diabetes, and cancer. LAI drugs are often preferred over oral medications due to their ability to provide more consistent and predictable therapeutic effects. The LAI market is highly competitive, with a number of large pharmaceutical companies and medical device manufacturers vying for market share. Some of the major players in the LAI market include Pfizer, Novartis, Sanofi, Merck, and Johnson & Johnson. Show Less Read more